ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Eledon Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.16+0.03 (+1.41%)
Close on Oct 19, 2026
- Market cap
- $245.44M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 16, 2020(first seen in filings) | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Oct 5, 2020 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Aug 9, 2017(first seen in filings) | 1-for-291 reverse | Earlier per-share figures multiplied by 291 |
| May 11, 2017 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |